Job description
Key Information
Salary: Dependent on relevant Postdoctoral experience. Future progression is based on annual performance review. If the candidate has not yet been awarded their PhD, the starting salary will be at £34,344 until the successful completion of their viva.
Duration of Contract: Fixed Term for 3 years
Hours per week: 35 hours per week (Full Time)
Closing Date: 2nd April 2023
Job Details
.
For general information on Post Doc's at The ICR can be found here.
Key Requirements
The successful candidate must have a PhD in Life Sciences (Biology, Genetics, Biochemistry, Molecular Biology) and proved experience of working in haematology.
The ICR has a workforce agreement stating that Postdoctoral Training Fellows can only be employed for up to 7 years as PDTF at the ICR, providing total postdoctoral experience (including previous employment at this level elsewhere) does not exceed 10 years
Department/Directorate Information:
The Epigenetics and Cancer team, directed by Professor Kristian Helin, studies the role of chromatin-associated proteins (epigenetics) in the regulation of transcription, cell fate decisions and in cancer. The team is also using functional genetic screens to identify potential novel targets for the development of anti-cancer therapy.
We encourage all applicants to access the job pack attached for more detailed information regarding this role. For further information discussion regarding the role, you may contact Kristian Helin at [email protected].
About The Institute of Cancer Research
Why work for us?
As a member of staff, you'll have exclusive access to a range of staff benefits.
The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.
The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.
We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.